SCOPUS 정보 검색 플랫폼

Volumn 56, Issue 9, 2001, Pages 675-682

Timing of analog research in medicinal chemistry

a NONE (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIMIGRAINE AGENT; AZATADINE; CANDESARTAN; CAPTOPRIL; CLODRONIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG ANALOG; ENALAPRIL; EPROSARTAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LANSOPRAZOLE; LISINOPRIL; LOSARTAN; METOCLOPRAMIDE; MICONAZOLE; NIFEDIPINE DERIVATIVE; OMEPRAZOLE; PANTOPRAZOLE; PIOGLITAZONE; PROPRANOLOL DERIVATIVE; PROTON PUMP INHIBITOR; RABEPRAZOLE; ROSIGLITAZONE; TELMISARTAN; TROGLITAZONE; UNINDEXED DRUG; VALSARTAN;

DRUG DESIGN; DRUG FORMULATION; DRUG MARKETING; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; MEDICAL RESEARCH; MOLECULAR BIOLOGY; PARTIAL DRUG SYNTHESIS; PHARMACOLOGICAL SCIENCE; REVIEW;

ANIMALS; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; RESEARCH;

EID: 0034843393 PISSN: 00317144 EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (7)

References (34)

1
- 0006909761
- IUPAC Recommendations: Glossary of terms used in the medicinal chemistry
- (1998) Pure and Applied Chemistry , vol.70 , pp. 1129

2
- 0003926232
- (1996) In Vivo , pp. 18
- Riefberg, V.¹ Pinkus, G.²

3
- 0004169648
- Academic Press, London, San Diego, New York, Boston, Sydney, Tokyo, Toronto
- (1996) The Practice of Medicinal Chemistry , pp. 207
- Wermuth, C.G.¹

4
- 0017578611
- U.S. Patent 4,046,889 (1976)
- (1977) Science , vol.196 , pp. 441
- Ondetti, M.A.¹ Rubin, B.² Cushman, D.W.³

6
- 0003898392
- (Takeda Chemical Industries Ltd.): U.S Patents 4,340,598 and 4,355,040
- Furakawa, Y.¹ Kishimoto, S.² Nishikawa, K.³

7
- 0026050837
- Eu. Patent 253,310 (1986)
- (1991) J. Med. Chem. , vol.34 , pp. 2525
- Carini, D.J.¹ Duncia, J.V.² Aldrich, P.E.³ Chiu, A.T.⁴ Johnson, A.L.⁵ Pierce, M.E.⁶ Price, W.A.⁷ Santella III, J.J.B.⁸ Wells, G.J.⁹ Wexler, R.R.¹⁰ Wong, P.C.¹¹ Yoo, S.-E.¹² Timmermanns, P.B.M.W.M.¹³

8
- 0003839465
- Hässle Läkemedel AB): EP 5129 (1978
- Sjöstrand, S.E.¹ Junggren, U.K.²

9
- 0022523138
- (1986) J. Med. Chem. , vol.29 , pp. 1327
- Lindberg, P.¹ Nordberg, P.² Alminger, T.³ Bränström, A.⁴ Wallmark, B.⁵

10
- 0029896612
- (1996) Int. J. Clin. Pharmacol. Ther. , vol.34 , Issue.SUPPL. NO. 1
- Zech, K.¹ Steinijans, V.W.² Huber, R.³ Radtke, H.W.⁴

11
- 0020353926
- (1982) Chem. Pharm. Bull. , vol.30 , pp. 3580
- Sohda, T.¹ Mizuno, K.² Imamiya, E.³ Suguyama, Y.⁴ Fujita, T.⁵ Kawamatsu, Y.⁶

12
- 0024516539
- (1989) J. Med. Chem. , vol.32 , pp. 421
- Yoshioka, T.¹ Fujita, T.² Kanai, T.³ Aizawa, Y.⁴ Hasegawa, K.⁵ Horikoshi, H.⁶

13
- 0003839467
- Warner-Lambert decided to discontinue marketing troglitazone (Rezuling®) for the treatment of type II diabetes due to safety and efficacy reasons (Warner-Lambert News Release in Prous Science Daily Essentials, March 22 2000)

14
- 0029016829
- (1995) J. Biol. Chem. , vol.270 , pp. 12953
- Lehmann, J.M.¹ Moore, L.B.² Smith-Oliver, T.A.³ Wilkison, W.O.⁴ Willson, T.M.⁵ Kliewer, S.A.⁶

15
- 0017055252
- (1976) J. Antibiotics , vol.29 , pp. 1346
- Endo, A.¹ Kuroda, M.² Tsujita, Y.J.³

16
- 0018939225
- (1980) Proc. Natl. Acad. Sci. U.S.A. , vol.77 , pp. 3957
- Alberts, A.W.¹ Chen, J.² Kuron, G.³ Hunt, V.⁴ Huff, J.⁵ Hoffman, C.⁶ Rothrock, J.⁷ Lopez, M.⁸ Joshua, H.⁹ Harris, E.¹⁰ Patchett, A.¹¹ Monaghan, R.¹² Currie, S.¹³ Stapley, E.¹⁴ Albers-Schonberg, G.¹⁵ Hensens, O.¹⁶ Hirschfield, J.¹⁷ Hoogsteen, K.¹⁸ Liesch, J.¹⁹ Springer, J.²⁰ more..

17
- 0025077819
- (1990) Drugs , vol.40 , pp. 583
- Todd, P.A.¹ Goa, K.L.²

18
- 0023160651
- (1987) J. Neurosci. , vol.7 , pp. 894
- Heuring, R.E.¹ Peroutka, S.J.²

19
- 0031019868
- (1997) Br. J. Clin. Pharmacol. , vol.43 , pp. 49
- Sciberras, D.G.¹ Polvino, W.J.² Gertz, B.J.³ Cheng, H.⁴ Stepanavage, M.⁵ Wittreich, J.⁶ Olah, T.⁷ Edwards, M.⁸ Mant, T.⁹

20
- 0003849816
- Fr. 1 313 758 (Soc. d'Etudes Scientifiques et Industrielles de l'Ille-de-France, 1961)

21
- 0026083233
- (1991) Eur. J. Clin. Pharmacol. , vol.40 , pp. 225
- MacDonald, T.M.¹

22
- 0025259702
- (1990) J. Pharmacol. Exp. Ther. , vol.252 , pp. 1378
- Craig, D.A.¹ Clarke, D.E.²

23
- 0003780716
- Janssen decided to stop marketing cisapride (Propulsid®) in the U.S. as of July 14, 2000 (Janssen News Release in Prous Science Daily Essentials, March 28, 2000)

24
- 0003832976
- (1991) J. Pharmacol. Exp. Ther. , vol.257 , pp. 2572
- Yoshida, N.¹ Ito, T.² Karasawa, T.³ Itoh, Z.⁴

25
- 0003849230
- Lednicer D. (ed.). ACS Professional Reference Book Washington, DC
- (1993) Chronicles of Drug Discovery , vol.3 , pp. 83
- Barnett, A.¹ Green, M.J.²

26
- 0017897357
- (1978) Br. J. Clin. Pharmacol. , vol.6 , pp. 31
- Clarke, C.H.¹ Nicholson, A.N.²

27
- 0003787178
- US 3 301 863 (Schering Corp., 1963)

28
- 84980305358
- (1972) J. Heteocycl. Chem. , vol.9 , pp. 1203
- Villani, F.J.¹ Wefer, E.A.² Mann, T.A.³ Peer, L.⁴ Levy, A.S.⁵

29
- 0001671788
- (2000) Annual Reports in Medicinal Chemistry , vol.35 , pp. 157
- Watkins, W.J.¹ Rebau, T.E.²

30
- 84910297496
- (1967) Arzneim.-Forsch. (Drug Res.) , vol.22 , pp. 22
- Fleckenstein, A.¹

31
- 0003852095
- US 3 485 847 (Bayer, 1967)

32
- 0022642174
- (1986) Arzneim.-Forsch. Drug Res. , vol.36 , pp. 200
- Harting, J.¹ Becker, K.H.² Bergmann, R.³ Bourgois, R.⁴ Enenkel, H.J.⁵ Fuchs, A.⁶ Jonas, R.⁷ Lettenbau, K.⁸ Minck, K.O.⁹ Schelling, P.¹⁰ Schulze, E.¹¹

33
- 0016819974
- (1975) Rev. Rheum. , vol.42 , pp. 699
- Meunier, C.¹ Chapuy, M.C.² Courpron, P.³ Vignon, E.⁴ Edouard, C.⁵ Bernard, J.⁶

34
- 0033851184
- (2000) Gastroenterology , vol.119 , pp. 631
- Lanza, F.L.¹ Hunt, R.H.² Thomson, A.B.R.³ Provenza, J.M.⁴ Blank, M.A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.